FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases

Hormone Molecular Biology and Clinical Investigation
Junichiro SonodaAmos Baruch

Abstract

Fibroblast growth factor 21 (FGF21) analogs and FGF21 receptor agonists (FGF21RAs) that mimic FGF21 ligand activity constitute the new "FGF21-class" of anti-obesity and anti-diabetic molecules that improve insulin sensitivity, ameliorate hepatosteatosis and promote weight loss. The metabolic actions of FGF21-class proteins in obese mice are attributed to stimulation of brown fat thermogenesis and increased secretion of adiponectin. The therapeutic utility of this class of molecules is being actively investigated in clinical trials for the treatment of type 2 diabetes and non-alcoholic steatohepatitis (NASH). This review is focused on various FGF21-class molecules, their molecular designs and the preclinical and clinical activities. These molecules include modified FGF21 as well as agonistic antibodies against the receptor for FGF21, namely the complex of FGF receptor 1 (FGFR1) and the obligatory coreceptor βKlotho (KLB). In addition, a novel approach to increase endogenous FGF21 activity by inhibiting the FGF21-degrading protease fibroblast activation protein (FAP) is discussed.

References

May 20, 2005·The Journal of Clinical Investigation·Alexei KharitonenkovArmen B Shanafelt
Oct 28, 2006·Endocrinology·Alexei KharitonenkovGarret J Etgen
Nov 30, 2006·American Journal of Physiology. Endocrinology and Metabolism·Haijun D SunPaul Kussie
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yasushi OgawaMakoto Kuro-o
Jul 3, 2007·Biochemical and Biophysical Research Communications·Thomas LundåsenMats Rudling
Jul 14, 2007·The Journal of Biological Chemistry·Benjamin C LinLuc R Desnoyers
Aug 24, 2007·The New England Journal of Medicine·Ted D AdamsSteven C Hunt
Aug 9, 2008·Endocrinology·Tamer CoskunAlexei Kharitonenkov
Jan 1, 2009·Journal of Cellular Physiology·Radmila MicanovicAlexei Kharitonenkov
Aug 12, 2009·Gastroenterology·Charis L JohnsonChristopher L Pin
Dec 19, 2009·The Journal of Biological Chemistry·Xinle WuYang Li
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xinle WuYang Li
Jul 30, 2010·Molecular Endocrinology·Klementina Fon TacerSteven A Kliewer
Aug 11, 2011·American Journal of Physiology. Endocrinology and Metabolism·Tomas B WaldénJan Nedergaard
Dec 17, 2011·Science Translational Medicine·Ai-Luen WuJunichiro Sonoda
Jan 24, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rama PaiDonna Dambach
Feb 4, 2012·Genes & Development·Matthew J PotthoffDavid J Mangelsdorf
Feb 4, 2012·Genes & Development·Ffolliott M FisherBruce M Spiegelman
Mar 28, 2012·Molecular and Cellular Biology·Regina GoetzMoosa Mohammadi
May 23, 2012·PloS One·Dorothy M FrenchLuc R Desnoyers
Jul 14, 2012·PloS One·Murielle M VéniantDavid J Lloyd
Sep 11, 2012·Cell Metabolism·Xunshan DingSteven A Kliewer
Nov 13, 2012·The Journal of Clinical Endocrinology and Metabolism·Kwok Leung OngUNKNOWN FIELD study investigators
Dec 5, 2012·PloS One·Andrew C AdamsAlexei Kharitonenkov

❮ Previous
Next ❯

Citations

Aug 22, 2017·Journal of Clinical Medicine·Alireza MorovatJoanna Poulton
Apr 27, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xu XuAnn-Hwee Lee
May 17, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·John E Mindur, Filip K Swirski
Dec 2, 2017·Nature Reviews. Drug Discovery·Paul J Carter, Greg A Lazar
Jul 3, 2019·Diabetologia·Jürgen Eckel
May 18, 2019·Endocrine Reviews·Matthew J WattMagdalene K Montgomery
Nov 2, 2019·Current Drug Targets·Ping WuHao Fang
Jul 11, 2020·The Biochemical Journal·Sarah JustesenBirgitte Andersen
Jul 28, 2019·The American Journal of Clinical Nutrition·Matthew Sherrier, Hongshuai Li
Sep 25, 2019·International Journal of Molecular Sciences·Úrsula Martínez-GarzaJoana Relat
Oct 4, 2017·Scientific Reports·Travis W BainbridgeJames A Ernst
Dec 19, 2019·Expert Opinion on Investigational Drugs·Kamran Qureshi, Brent A Neuschwander-Tetri
Mar 14, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Luthfiyyah MutsnainiRina Yu
Nov 1, 2020·Nature Reviews. Gastroenterology & Hepatology·Tatiana Kisseleva, David Brenner
Oct 30, 2020·Diabetes & Metabolism Journal·Soung Won Jeong
Nov 25, 2020·Geriatrics·Carla PignattiSilvia Cetrullo
Jun 14, 2021·Reviews in Endocrine & Metabolic Disorders·Shuang HuaDewei Ye

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
biopsies
surgical resection
gastric bypass

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.